Hans is former CEO of Prosensa (acquired by BioMarin). His previous assignments include leadership roles at Genzyme and Organon. He served on the boards of Hansa Biopharma, Wilson Therapeutics (acquired by Alexion), Sobi, Asceneuron, InteRNA, Therachon (acquired by Pfizer) and VectivBio (acquired by Ironwood).
Share awards: 31,616
Shareholdings: View shareholding
Education: Pharmacist degree (PharmD) from the University of Utrecht.
Other assignments: Chairman of Microbiotica Ltd. Board member of Pharvaris NV and Organon NV. TopTeam member of the Dutch Top Sector Life Sciences & Health. Advisor to various organisations in Life Sciences & Health.
Independent of the company and its senior management and independent of major shareholders of the company.